ライフサイエンスコーパス: calf serum

1 dium containing 2 x amino acids and 5% fetal calf serum).

2 media with or without pyruvate and 1% fetal calf serum.

3 phosphodiesterase, S1 nuclease and in fetal calf serum.

4 microg mL(-1)) for IgY antibody in undiluted calf serum.

5 lex was completely inactivated with 2% fetal calf serum.

6 5 pg mL(-1) (25 fM) for IL-6 in 10 microL of calf serum.

7 te-buffered saline (PBS) buffer and in fetal calf serum.

8 500f gmL(-1) for the 3 proteins in undiluted calf serum.

9 ce of tissue culture medium containing fetal calf serum.

10 ltured in growth medium containing 10% fetal calf serum.

11 gent hydrogen peroxide and slightly by fetal calf serum.

12 erived growth factor BB and 2% or less fetal calf serum.

13 these dissolves without aggregation in fetal calf serum.

14 n of WI38 cells in the presence of 10% fetal calf serum.

15 ut trypsin in the presence of 5 to 10% fetal calf serum.

16 red with cells cultured in 1% dialyzed fetal calf serum.

17 th either 50% autologous plasma or 10% fetal calf serum.

18 ssential modified Eagle's medium + 10% fetal calf serum.

19 s fluid, and to remove bovine IgG from fetal calf serum.

20 cco's modified Eagle's medium with 10% fetal calf serum.

21 ytic cell phenotype in the presence of fetal calf serum.

22 alone or in EMEM supplemented with 10% fetal calf serum.

23 tal mouse calvariae, and cultured with fetal calf serum (10% for osteoblast-like cells and 2% for ost

24 us buffer (PBS) or in media containing fetal calf serum (10%), is rapidly taken-up into cultured macr

25 Fetal calf serum (10%)- and PDGF (10 ng/mL)-stimulated increas

26 us 19 +/- 6%, P = 0.01) as well as 10% fetal calf serum (19 +/- 7 versus 31 +/- 6%, P = 0.03).

27 ific antigen (PSA) in 10 microL of undiluted calf serum, a mass detection limit of 40 fg.

28 Activating cellular contractile forces by calf serum and disrupting F-actin by cytochalasin D yiel

29 total serum protein were confirmed when both calf serum and human serum were spiked with technical mi

30 somers in technical mixtures spiked to whole calf serum and human serum.

31 criptase as well as their stability in fetal calf serum and in CEM cell extracts.

32 inimal essential media (EMEM) with 10% fetal calf serum and Pluronic F-68 or F-127 in concentrations

33 re grown in low serum conditions (0.1% fetal calf serum) and is observed selectively with transformed

34 ly used clinically (but which contains fetal calf serum), and a serum-free alternative, M2 (melanocyt

35 le's medium, nonessential amino acids, fetal calf serum, and beta-mercaptoethanol.

36 Eagle's medium supplemented with 10% newborn calf serum, and during the period of experimentation wer

37 stimulation by lysophosphatidic acid, fetal calf serum, and epidermal growth factor retain activated

38 reproducibility, was studied using undiluted calf serum, and excellent recoveries in the range of 94.

39 , cytokines, growth factors, hormones, fetal calf serum, and serum extracts.

40 The effect of gamma interferon, fetal calf serum, and the recombination proficiency of E. coli

41 er, was sensitive to killing in precolostral calf serum, and was avirulent in pigs at an intratrachea

42 lomerular injury, the effect of PF4 on fetal calf serum- and platelet-derived growth factor (PDGF)-in

43 12-O-tetradecanoylphorbol-13-acetate, fetal calf serum, anisomycin, UV irradiation, tumor necrosis f

44 Estrogen levels present in fetal calf serum are sufficient to maintain AIB1 mRNA and prot

45 RPMI 1640 medium supplemented with 15% fetal calf serum at 37 degrees C with 5% CO(2) in air.

46 cultured in brucella broth containing fetal calf serum (BBF) alone or supplemented with 100 microM N

47 hanically polished in the presence of bovine calf serum (BCS) in a hip simulator.

48 er physiological conditions (e.g. 10% bovine calf serum (BCS), neutral pH, nanomolar concentrations o

49 lactosidase, bovine serum albumin, nor fetal calf serum caused an increase in outflow resistance.

50 onditions of high population density and low calf serum concentration used in the assay for transform

51 l-based therapies using cells grown in fetal calf serum-containing media, an antibody response to bov

52 Response of cells to stimulation by fetal calf serum could be reproduced by the model, further sup

53 sformed foci when grown to confluence in 10% calf serum (CS).

54 Calf serum (CS; 30%) elicited a monotonic increase in fo

55 Charcoal filtration of fetal calf serum eliminated the block of PPARgamma, whereas re

56 Fetal calf serum enhanced the stimulatory effect of overexpres

57 ly in response to IGF-I but not to 10% fetal calf serum, epidermal growth factor, fibroblast growth f

58 Growth factors such as fetal calf serum, epidermal growth factor, phorbol 12-myristat

59 Dulbecco's modified Eagle's medium and fetal calf serum, even with supplemental growth factors.

60 Cells cultured in 10% dialyzed fetal calf serum exhibited decreased synthesis of more highly

61 Under conditions of limited calf-serum exposure, the infected rat myocytes manifeste

62 h was measured after 3 to 7 days in 1% fetal calf serum (FCS) + RPMI 1640.

63 Fetal calf serum (FCS) and bone morphogenetic proteins (BMPs)

64 d by stimulation of proliferation with fetal calf serum (FCS) and platelet-derived growth factor-BB (

65 sCD44 was isolated from human or fetal calf serum (FCS) by urea solubilization and immunoprecip

66 in modified Ham's F10 medium with 10% fetal calf serum (FCS) for 10 days.

67 endent and affected by the presence of fetal calf serum (FCS) in the growth medium.

68 ulture medium supplemented with 1) 15% fetal calf serum (FCS) only; 2) 1% FCS only; 3) 1% FCS and nic

69 ulated over 50-fold by the addition of fetal calf serum (FCS) to the cell culture medium (RPMI medium

70 Human TM cells grown in 10% fetal calf serum (FCS) were incubated in 0.1% FCS with 1, 10,

71 um (minimum essential medium, MEM) and fetal calf serum (FCS) were probed by XANES and EXAFS.

72 HAVSMCs stimulated with fetal calf serum (FCS) were pulsed with bromodeoxyuridine (Brd

73 deficiency and identified a factor in fetal calf serum (FCS) which is capable of mediating uptake of

74 ultured in medium supplemented with 5% fetal calf serum (FCS), anti-CD3 antibody, and interleukin-2 (

75 a containing various concentrations of fetal calf serum (FCS), bovine serum albumin, or porcine retin

76 as control cells when cultured in 0.5% fetal calf serum (FCS), but failed to undergo fetal calf serum

77 + rods develop in the presence of 10% foetal calf serum (FCS), large numbers develop in the absence o

78 When exposed to 10% fetal calf serum (FCS), there were no differences in growth ra

79 ith adherent cells (macrophages) in 1% fetal calf serum (FCS)- or adult mouse serum (AMS)-supplemente

80 cephalic cells cultured in 0.5 or 2.0% fetal calf serum (FCS)-containing medium for 48 hr showed incr

81 oncentration-dependent potentiation of fetal calf serum (FCS)-stimulated cell proliferation.

82 alf serum (FCS), but failed to undergo fetal calf serum (FCS)-stimulated hyperplasia when grown on st

83 ure using medium supplemented with 10% fetal calf serum (FCS).

84 L TGF-beta2 (TGF-beta2-treated group), fetal calf serum (FCS)/phosphate-buffered saline (PBS; FCS/PBS

85 uiescent RASMCs with 1 mM homocysteine or 2% calf serum for 36 h increased cyclin A mRNA levels by 8-

86 d Eagle's medium supplemented with 10% fetal calf serum for up to four passages.

87 ic MM cell line (or, similarly, by 10% fetal calf serum), forms branching tubules under three-dimensi

88 e of cytokines and 5% heat-inactivated fetal calf serum (HI-FCS).

89 o bind Rac are nonetheless well activated by calf serum, implying that this stimulus may induce Pak a

90 by moderately reducing the concentration of calf serum in the medium during low-density passages, wh

91 ted in culture medium containing 15% newborn calf serum, in serum-free culture medium containing eith

92 TGF-beta2, 1 ng/ml TGF-beta1, or 15% newborn calf serum induced the expression of EDA+ and EDB+ mRNA

93 Exposure to fetal calf serum induces GRP cells to differentiate into A2B5-

94 A combination of fetal calf serum, insulin-like growth factor-I, nicotinamide a

95 s was achieved in vitro by addition of fetal calf serum, insulin-like growth factor-I, nicotinamide,

96 -1, platelet-derived growth factor, or fetal calf serum, MCs initiated rapid HA synthesis associated

97 f a base medium supplemented with 2% newborn calf serum, Mg2+, Cu2+, Fe2+, Zn2+, Mn2+, and 1 mg of ly

98 The human serum (HS) and new-born calf serum (NCS) spiked with antigen-specific antibody w

99 g growth factor beta-1 (TGF-beta1) and fetal calf serum on proteoglycan synthesis in corneal fibrobla

100 evelopmental stage and the presence of fetal calf serum or a larval extract in the medium.

101 12% 48 hours after incubation with 10% fetal calf serum or epidermal growth factor (5 ng/mL), respect

102 ad been passaged in growth medium containing calf serum or horse serum.

103 idal ecdysone analog RH5992 for either fetal calf serum or larval extract also results in activation

104 , is expressed at elevated levels after FGF, calf serum or phorbol ester treatment of fibroblasts in

105 confluence and then cultured with either 10% calf serum or with 100 nM RA for 0 to 72 hours.

106 k of mitogenic potential, as the addition of calf serum, or epidermal growth factor, stimulated DNA s

107 FGF-2, calf serum, platelet-derived growth factor-BB, and phorb

108 calf serum than in that grown with 15% fetal calf serum, suggesting that factors present in the serum

109 tic effect of Tpo was observed both in fetal calf serum-supplemented and serum-depleted medium and wa

110 a concentration of 1 cell per well in fetal calf serum-supplemented and serum-depleted medium.

111 ium (SFM) or SFM supplemented with 10% fetal calf serum, TGF-gamma1, TGF-beta2, TGF-beta3, basic fibr

112 cultures grown in the presence of 2.5% fetal calf serum than in that grown with 15% fetal calf serum,

113 s well as the individual proteins from fetal calf serum that are associated with lipoplexes.

114 e cultured in the continuous presence of 10% calf serum, the high level of intracellular TKT protein

115 LPS-treated RAW 264.7 macrophages and fetal calf serum-treated mouse embryonic fibroblasts, TTP prot

116 fficiency of the stable complex in 15% fetal calf serum was 30% of that obtained in the absence of se

117 on rate of the RAS-transformed cells in 0.5% calf serum was also slower with menin overexpression.

118 When fetal calf serum was included in cartilage cultures, MMP activ

119 Cell proliferation in response to fetal calf serum was later determined in the presence and abse

120 co's minimal essential medium plus 10% fetal calf serum, were added to new wounds.

121 dium of cells grown either on horse serum or calf serum with free queuine had no effect on frameshift